Skip to Content
Merck
CN
All Photos(1)

Documents

G005691

LC/MS Analysis of CYP2D6 Inhibitors on Ascentis® Express HILIC

application for HPLC

Sign Into View Organizational & Contract Pricing


About This Item

technique(s)

HPLC: suitable

test parameters

column: Ascentis Express HILlC, 10 cm x 2.1 mm I.D., 2.7 μm particles (53939-U)
mobile phase: 5 mM ammonium formate in 2:98 (v/v) water:acetonitrile
flow rate: 1.2 mL/min
column temp.: 50 °C
detector: ESI(+), m/z 100-400
injection: 0.5 μL

suitability

application for HPLC

application(s)

clinical
life science and biopharma

Analysis Note

This application demonstrates the suitability of the Ascentis Express HILIC for the analysis of CYP2D6 Inhibitors.

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

Analyte

Description

    Imipramine

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service